. Author manuscript; available in PMC: 2021 Oct 22.

Published in final edited form as: Int J Toxicol. 2021 Jul 19;40(5):442–452. doi: 10.1177/10915818211031239

Table 5:

Coagulation results

Group	Treatment	Gender	PT (sec)		FIB (mg/dL)
Group	Treatment	Gender	Day 31	Day 43	Day 31	Day 43
1	0.9% Saline (control)	M	15.77	15.55	377.1	367.0
2	0.5 mg CPG 7909	M	16.55^*	15.91	528.4^*	366.3
3	AV7909 Lot 1	M	16.97^*	16.05	858.7^*	356.3
4	AV7909 Lot 2	M	17.22^*	16.45^*	798.9^*	409.2
1	0.9% Saline (control)	F	15.30	15.30	284.7	279.9
2	0.5 mg CPG 7909	F	15.21	15.57	378.4^*	253.0
3	AV7909 Lot 1	F	16.44^*	15.77^*	749.6^*	248.1
4	AV7909 Lot 2	F	16.66^*	16.10^*	605.2^*	255.7

M - male; F - female; PT – prothrombin time; FIB – Fibrinogen

- Significantly different from the control value, p < 0.05